IGI will give Glenmark Pharma rights to commercialise in India and all emerging markets
Rohit Jawa will step down as CEO and MD on July 31, 2025 to pursue the next chapter in his personal and professional journey, the company said in a filing.
Get over your FOMO of knowing what's happening. Never miss what matters to you!